Kinesiotape for hand lymphoedema.

Not Applicable

Recruiting

• Conditions: Secondary hand lymphoedema; Cancer - Any cancer; Physical Medicine / Rehabilitation - Physiotherapy

• Registration Number: ACTRN12618001232224
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-07-23
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

•Adults aged over 18
•Unilateral secondary upper limb lymphoedema affecting the hand, diagnosed by a health care practitioner.
•At least 6 months since cancer-related treatments were completed (Chemotherapy, Radiation therapy or Surgery).
•No active treatment for lymphoedema at least 1 month prior to the study commencing day (CDT, bandaging).
•Capability to communicate and comprehend English language.
•Willing to not wear hand or arm compression garment for 2 days.

Exclusion Criteria

•Active disease or infection that might lead to swelling as well as conditions such as heart or kidney disease, or pregnancy.
•Medication affecting volume changes such as diuretic therapy.
•Pacemaker or in-dwelling defibrillator.
•Allergy to Kinesiotape material (skin test required).
•Skin conditions such as wounds or infection.
•Irremovable bracelet or ring.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
I) Changes in physical measurements (volume of extracellular fluid assessed by Bio Impedance Spectroscopy (BIS), finger and hand size assessed by tape measures). Composite primary outcome. [2 days post start of intervention];II)Changes in dermal thickness assessed by Ultrasound (US).[2 days post start of intervention.];III)Changes in Lymphoedema symptoms assessed by the Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A) modified for the hand.[2 days post start of intervention.]

Secondary Outcome Measures

Name	Time	Method
I)Change in patient-reported outcomes assessed by Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.<br>[2 days post start of intervention.];II) Change in patient-reported outcomes assessed by Lymphoedema Quality of Life (LYMQOL) questionnaire modified for the hand.<br><br>[2 days post start of intervention.];III)Change in volume of extracellular fluid in the forearm assessed by BIS.<br><br>[2 days post start of intervention.];IV)Change tissue compliance, as assessed by pitting test and palpation for presence of fibrotic regions by clinical examination.<br><br>[2 days post start of intervention.];V) Change in patient-reported outcomes assessed by participant nominated activities and lymphoedema perception questions.<br>Composite secondary outcome.[2 days post start of intervention.]